Protective effect of taurohyodeoxycholic acid from Pulvis Fellis Suis on trinitrobenzene sulfonic acid induced ulcerative colitis in mice

European Journal of Pharmacology

Volumn 670, Issue 1, 2011, Pages 229-235

  He, Jiao ^a   Liang, Jinru ^a   Zhu, Sha ^a   Zhao, Wenna ^a   Zhang, Yongmin ^b   Sun, Wenji ^a  

^a NORTHWEST UNIVERSITY   (China)

^b Université Pierre et Marie Curie   (France)

Author keywords

COX 2; IL 6; Keywords; MPO; Taurohyodeoxycholic acid; TNF ; Ulcerative colitis

Indexed keywords

BILE ACID; CYCLOOXYGENASE 2; INTERLEUKIN 6; MYELOPEROXIDASE; SALAZOSULFAPYRIDINE; TAUROHYODEOXYCHOLIC ACID; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BILE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; ENZYME ACTIVITY; INTESTINE PROTECTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; PROTECTION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; ULCERATIVE COLITIS;

ANIMALS; BODY WEIGHT; COLITIS, ULCERATIVE; COLON; DRUGS, CHINESE HERBAL; GENE EXPRESSION REGULATION; MALE; MICE; PEROXIDASE; TAURODEOXYCHOLIC ACID; TRINITROBENZENESULFONIC ACID;

EID: 80054728004     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.08.036     Document Type: Article

References (49)

1. E. Akgun, C. Caliskan, H.A. Celik, A.O. Ozutemiz, M. Tuncyurek, and H.H. Aydin Effects of N-acetylcysteine treatment on oxidative stress in acetic acid-induced experimental colitis in rats J. Int. Med. Res. 33 2005 196 206 (Pubitemid 40372435)
2. M. Angelico, L. Baiocchi, A. Nistri, A. Franchitto, P.D. Guardia, and E. Gaudio Effect of taurohyodeoxycholic acid, a hydrophilic bile salt, on bile salt and biliary lipid secretion in the rat Dig. Dis. Sci. 39 1994 2389 2397 (Pubitemid 24350021)
3. S. Ardizzone, and G.B. Porro Biologic therapy for inflammatory bowel disease Drugs 65 2005 2253 2286 (Pubitemid 41571985)
4. L. Baidoo, and G.R. Lichtenstein What next after infliximab? Am. J. Gastroenterol. 100 2005 80 83 (Pubitemid 41623273)
5. L. Baiocchi, G. Alpini, S. Glaser, M. Angelico, D. Alvaro, H. Francis, M. Marzioni, J.L. Phinizy, B. Barbaro, and G. LeSage Taurohyodeoxycholate- and tauroursodeoxycholate-induced hypercholeresis is augmented in bile duct ligated rats J. Hepatol. 38 2003 136 147 (Pubitemid 36169622)
6. D.C. Beffa, A.J. Fischman, S.P. Fagan, V.F. Hamrahi, K.W. Paul, M. Kaneki, Y.M. Yu, R.G. Tompkins, and E.A. Carter Simvastatin treatment improves survival in a murine model of burn sepsis: role of interleukin 6 Burns 37 2011 222 226
7. K. Benamar, E.B. Geller, and M.W. Adler Effect of a μ-opioid receptor-selective antagonist on interleukin-6 fever Life Sci. 70 2002 2139 2145 (Pubitemid 34219464)
8. D.G. Binion, M.F. Otterson, and P. Rafiee Curcumin inhibits VEGF-mediated angiogenesis in human intestinal microvascular endothelial cells through COX-2 and MAPK inhibition Gut 57 2008 1509 1517
9. M. Buraczynska, L. Jozwiak, P. Ksiazek, E. Borowicz, and P. Mierzicki Interleukin-6 gene polymorphism and faster progression to end-stage renal failure in chronic glomerulonephritis Transl. Res. 150 2007 101 105 (Pubitemid 47081454)
10. L. Camacho-Barquero, I. Villegas, J.M. Sánchez-Calvo, E. Talero, S. Sánchez-Fidalgo, V. Motilva, and C. Alarcón de la Lastra Curcumin, a Curcuma longa constituent, acts on MAPK p38 pathway modulating COX-2 and iNOS expression in chronic experimental colitis Immunopharmacol. Int. 7 2007 333 342 (Pubitemid 46186172)
11. G.A. Castro Myeloperoxidase and intestinal inflammation Gastroenterology 88 1985 1294 1295
12. A. Cetinkaya, E. Bulbuloglu, E.B. Kurutas, H. Ciralik, B. Kantarceken, and M.A. Buyukbese Beneficial effects of N-acetylcysteine on acetic acid-induced colitis in rats Tohoku J. Exp. Med. 206 2005 131 139 (Pubitemid 40895042)
13. S.J.H. Deventer Tumor necrosis factor and Crohn's disease Gut 40 1997 443 448 (Pubitemid 27204920)
14. R.D. Di Paola, E. Esposito, E. Mazzon, L. Riccardi, R. Caminiti, R.D. Toso, G. Pressi, and S. Cuzzocrea Teupolioside, a phenylpropanoid glycosides of Ajuga reptans, biotechnologically produced by IRBN22 plant cell line, exerts beneficial effects on a rodent model of colitis Biochem. Pharmacol. 77 2009 845 857
15. I.J. Fuss, T. Marth, M.F. Neurath, G.R. Pearlstein, A. Jain, and W. Strober Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice Gastroenterology 117 1999 1078 1088 (Pubitemid 29512666)
16. Y. Gonzalez-Lama, I. Fernandez-Blanco, A. Lopez-SanRoman, C. Taxonera, B. Casis, and S. Tabernero Open-label infliximab therapy in ulcerative colitis: a multicenter survey of results and predictors of response Hepatogastroenterology 55 2008 1609 1614
17. X. Guo, W.P. Wang, J.K. Ko, and C.H. Cho Involvement of neutrophils and free radicals in the potentiating effects of passive cigarette smoking on inflammatory bowel disease in rats Gastroenterology 117 1999 884 892 (Pubitemid 29468231)
18. S.B. Hanauer, and D.H. Present The state of the art in the management of inflammatory bowel disease Rev. Gastroenterol. Disord. 3 2003 81 92 (Pubitemid 36705487)
19. J. He, J. Li, Y.M. Zhang, Y.G. He, and W.J. Sun Simultaneous determination of four major conjugated cholic acids in dry bile of Sus scrofa domestica Brisson by MEKC Chromatographia 71 2010 947 951
20. J.S. Hyams, T. Lerer, A. Griffiths, M. Pfefferkorn, S. Kugathasan, and J. Evans Longterm outcome of maintenance infliximab therapy in children with Crohn's disease Inflamm. Bowel Dis. 15 2009 816 822
21. H. Ito, M. Takazoe, Y. Fukuda, T. Hibi, K. Kusugami, A. Andoh, T. Matsumoto, T. Yamamura, J. Azuma, N. Nishimoto, K. Yoshizaki, T. Shimoyama, and T. Kishimoto A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease Gastroenterology 126 2004 989 996 (Pubitemid 38451170)
22. T. Kitahora, K. Suzuki, H. Asakura, T. Yoshida, M. Suematsu, M. Watanabe, S. Aiso, and M. Tsuchiya Active oxygen species generated by monocytes and polymorphonuclear cells in patients in Crohn's disease Dig. Dis. Sci. 33 1998 951 955
23. L. Kruidenier, I. Kuiper, C. Lamers, and H.W. Verspaget Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants J. Pathol. 201 2003 28 36 (Pubitemid 37121200)
24. G.R. Lichtenstein Approach to corticosteroid-dependent and corticosteroid-refractory Crohn's disease Inflamm. Bowel Dis. 7 Suppl. 1 2001 S23 S29
25. P. Loria, M. Bozzoli, M. Concari, M.E. Guicciardi, F. Carubbi, M. Bertolotti, D. Piani, A. Nistri, M. Angelico, M. Romani, and N. Carulli Effect of taurohyodeoxycholic acid on biliary lipid secretion in humans Hepatology 25 1997 1306 1314 (Pubitemid 27250745)
26. J.Y. Luo, J.C. Cao, X.L. Jiang, and H.F. Cui Effect of low molecular weight heparin rectal suppository on experimental ulcerative colitis in mice Biomed. Pharmacother. 64 2010 441 445
27. A.R. Martin, I. Villegas, M. Sanchez-Hidalgo, and C. Alarcón de la Lastra The effects of resveratrol, a phytoalexin derived from red wines, on chronic inflammation induced in an experimentally induced colitis model Br. J. Pharmacol. 147 2006 873 885
28. A.D. Millar, D.S. Rampton, C.L. Chander, A.W.D. Claxson, and D.R. Blake Evaluating the antioxidant potential of newtreatments for inflammatory bowel disease in a rat model of colitis Gut 39 1996 407 415 (Pubitemid 26338530)
29. G.P. Morris, P.L. Beck, M.S. Herridge, W.T. Depew, M.R. Szewczuk, and J.L. Wallace Hapten-induced model of chronic inflammation and ulceration in the rat colon Gastroenterology 96 1989 795 803 (Pubitemid 19057602)
30. M.F. Neurath, I. Fuss, B.L. Kelsall, E. Stuber, and W. Strober Antibodies to interleukin 12 abrogate established experimental colitis in mice J. Exp. Med. 182 1995 1281 1290
31. D. Owczarek, D. Cibor, M. Szczepanek, and T. Mach Biological therapy of inflammatory bowel disease Pol. Arch. Med. Wewn. 119 2009 84 88
32. C.D. Packey, and R.B. Sartor Interplay of commensal and pathogenic bacteria, genetic mutations, and immunoregulatory defects in the pathogenesis of inflammatory bowel diseases J. Int. Med. 263 2008 597 606 (Pubitemid 351678591)
33. A.P.R. Paiotti, S.J. Miszputen, C.T.F. Oshima, H.O. Costa, D.A. Ribeiro, and M. Franco Effect of COX-2 inhibitor after TNBS-induced colitis in wistar rats J. Mol. Histol. 40 2009 317 324
34. M.J. Palmen, C.D. Dijkstra, M.B. van der Ende, A.S. Pena, and E.P. van Rees Anti-CD11b/CD18 antibodies reduce inflammation in acute colitis in rats Clin. Exp. Immunol. 101 1995 351 356
35. M. Paolini, L. Pozzetti, F. Piazza, G. Cantelli-Forti, and A. Roda Bile acid structure and selective modulation of murine hepatic cytochrome P450-linked enzymes Hepatology 30 1999 730 739 (Pubitemid 29409418)
36. Pharmacopoeia Committee Pharmacopoeia of the People's Republic of China Vol. 1 2010 China Medical Science and Technology Publishing Press Beijing, BJ 299 [M]
37. A. Polgar, M. Brozik, S. Toth, M. Holub, K. Hegyi, and A. Kadar Soluble interleukin-6 receptor in plasma and in lymphocyte culture supernatants of healthy individuals and patients with systemic lupus erythematosus and rheumatoid arthritis Med. Sci. Monit. 6 2000 13 18 (Pubitemid 30158232)
38. D. Rachmilewitz, F. Karmeli, K. Takabayashi, T. Hayashi, L. Leider-Trejo, J. Lee, L.M. Leoni, and E. Raz Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis Gastroenterology 122 2002 1428 1441 (Pubitemid 34465184)
39. W. Reinisch, C. Gasché, W. Tillinger, J. Wyatt, C. Lichtenberger, M. Willheim, C. Dejaco, T. Waldhör, S. Bakos, H. Vogelsang, A. Gangl, and H. Lochs Clinical relevance of serum interleukin-6 in Crohn's disease: single point measurements, therapy monitoring, and prediction of clinical relapse Am. J. Gastroenterol. 94 1999 2156 2164 (Pubitemid 29374547)
40. F. Rizzello, P. Gionchetti, A. Venturi, C. Morselli, and M. Campieri Review article: the management of refractory Crohn's disease Aliment. Pharmacol. Ther. 16 Suppl. 4 2002 40 47 (Pubitemid 34595617)
41. A. Roda, F. Piazza, M. Baraldini, E. Speroni, M.C. Guerra, C. Cerré, and G.C. Forti Taurohyodeoxycholic acid protects against taurochenodeoxycholic acid-induced cholestasis in the rat Hepatology 27 1998 520 525 (Pubitemid 28081068)
42. J.M. Sánchez-Calvo, I. Villegas, S. Sánchez-Fidalgo, L. Camacho-Barquero, E. Talero, V. Motilva, and C. Alarcón de la Lastra Protective effect of curcumin, a Curcuma longa constituent, in early colonic inflammation in rats Drug Dev. Res. 70 2009 425 437
43. S. Sánchez-Fidalgo, I. Villegas, A. Martín, M. Sánchez-Hidalgo, and C. Alarcón de la Lastra PARP inhibition reduces acute colonic inflammation in rats Eur. J. Pharmacol. 563 2007 216 223
44. C.L.L. Saw, Y. Huang, and A.N. Kong Synergistic anti-inflammatory effects of low doses of curcumin in combination with polyunsaturated fatty acids: docosahexaenoic acid or eicosapentaenoic acid Biochem. Pharmacol. 79 2010 421 430
45. A.M. Sciutto, P. Columbo, and R. Germogli The new biliary acid taurohyodeoxycholic acid in the treatment of gallstones Acta Toxicol. Et. Ther. 17 1996 323 337
46. L.R. Song Dictionary of Modern Chinese Medicine vol. 2 2001 People's Medical Publishing House Press Beijing, BJ 1991
47. E. Talero, S. Sánchez-Fidalgo, C. Alarcón de la Lastra, M. Illanes, J.R. Calvo, and V. Motilva Acute and chronic responses associated with adrenomedullin administration in experimental colitis Peptides 29 2008 2001 2012
48. B.S. Thippeswamy, S. Mahendran, M.I. Biradar, P. Raj, K. Srivastava, S. Badami, and V.P. Veerapur Protective effect of embelin against acetic acid induced ulcerative colitis in rats Eur. J. Pharmacol. 654 2011 100 105
49. M. Zhang, Y. Long, Y. Sun, Y.K. Wang, Q. Li, H.J. Wu, Z.J. Guo, Y.H. Li, Y.B. Niu, C. Li, L. Liu, and Q.B. Mei Evidence for the complementary and synergistic effects of the three-alkaloid combination regimen containing berberine, hypaconitine and skimmianine on the ulcerative colitis rats induced by trinitrobenzene-sulfonic acid Eur. J. Pharmacol. 651 2011 187 196